Channel 1 Los Angeles
“Our government firmly believes in the importance of protecting IP, and recognizes the integral role that industry has played in innovating to develop and deliver life-saving COVID-19 vaccines.
“Canada is ready to discuss proposals on a waiver for intellectual property (IP) protection, in particular for COVID-19 vaccines, under the WTO Agreement on TRIPS.
“Since the introduction of the IP waiver proposal, Canada has actively worked with partners to identify barriers to vaccine access—many of which are unrelated to IP, such as supply chain constraints.
“We remain committed to finding solutions and reaching an agreement that accelerates global vaccine production and does not negatively impact public health.
“Canada has always been, and remains, a strong advocate for equitable access to vaccines and medical supplies around the world through our support for the Access to COVID-19 Tools (ACT) Accelerator and the COVAX Facility. To date, we have announced $940 million to support low- and middle-income countries to access COVID-19 vaccines, tests, and treatments because we understand that the pandemic isn’t over anywhere, until it is over everywhere.”